Analyzing the impact of systems-based hematologist in the healthcare system at an academic medical center.
Ming Y LimCharles S GreenbergPublished in: Journal of thrombosis and thrombolysis (2019)
Over the next decade, there is a predicted shortage of nonmalignant hematologist to maintain the workforce in the United States. To address this, the American Society of Hematology described the creation of the healthcare systems-based hematologist (SBH). The role of SBH has the potential to provide high-value, cost-conscious care to the healthcare system. In 2011, an Anticoagulation and Bleeding Management Medical Directorship position for a SBH was created at our healthcare system. We described our 6-year experience as SBH at a 750-bed tertiary academic medical center to improve clinical outcomes while reducing costs. Via four different initiatives, we were able to provide high-value, cost-conscious care as SBH by reducing cost of heparin-induced thrombocytopenia management, optimizing blood product utilization using goal-directed algorithms, reducing inappropriate thrombophilia testing and improving inferior vena cava filter retrieval rates. To ensure continuing success as a SBH, business plans need to include education, enforcement, monitoring, feedback, validation of safety and outcomes and a shared vision among leadership.
Keyphrases
- healthcare
- inferior vena cava
- quality improvement
- atrial fibrillation
- palliative care
- venous thromboembolism
- pulmonary embolism
- machine learning
- public health
- affordable care act
- health insurance
- type diabetes
- diabetic rats
- metabolic syndrome
- vena cava
- pain management
- growth factor
- skeletal muscle
- chronic pain
- insulin resistance
- climate change